These data suggest that SPARC and MMP-2 may play opposing roles in the ECM remodeling during obesity and after bariatric surgery, thereby regulating muscle insulin sensitivity. The gene discussed is SPARC; the disease is obesity due to melanocortin 4 receptor deficiency.